Investigator Studies Program (MISP): HPV
Effective January 2019, the HPV Investigator Studies Program (MISP) Committee will accept proposals within our current areas of interest (AOI) up to June 21, 2019. This is a competitive process that will be conducted on July 24, 2019 by the HPV MISP. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below.

The following areas are of interest to Investigator Studies Program Committee:

Research that
  • Studies on the proportion of head and neck cancer in a region or country that is due to HPV
  • Epidemiological studies of HPV vaccine effectiveness in head and neck cancer
  • Pilot study on the beneficial health effects of vaccination with the 9-valent vaccine followed by cervical screening and treatment of prevalent disease in women who are ≥27 years old
  • Exploratory studies that explore the association of HPV with newer diseases and cancers
  • Exploratory immunogenicity studies of a 2-dose vaccination regimen over 6 or over 12 months in men and women older than 14 years old (Consultation with grants program prior to application is advised)

Please complete a full protocol and detailed budget via Visiontracker, the Company's on-line study management system (in US) or your MSD country representative (outside US). The proposals will be collectively reviewed and selected by the HPV MISP Committee.

Critical Activities and Timelines:
Activity 1st Review Cycle
Full Protocol Submission with Detailed Budget June 21, 2019
Final Comments to Investigator August 23, 2019

MISP Information
This site is intended for US investigators only. Investigators outside of the US interested in submitting research proposals to the Investigator Studies Program should contact their local MSD office.